Award notice Supplies
Levering polyvalente immunoglobulinen voor subcutane toediening
Notice published in Dutch. The AI analysis summarises it for you in your language.
- Public buyer
- AZ Alma
Eeklo - Place of performance
- 9900 Eeklo, East Flanders
- Planned end of contract
- 2 August 2030
likely re-tender around February 2030 - Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 8 July 2026
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Wij nodigen u uit tot het indienen van een offerte voor de levering van polyvalente immunoglobulinen voor subcutane toediening (ATC J06BA01), in volgende sterktes: - 1g normaal humaan immunoglobuline - 2g normaal humaan immunoglobuline - 4g normaal humaan immunoglobuline Het betreft een raamovereenkomst voor de gespecifieerde levering binnen de afgesproken termijn en onder de voorwaarden zoals opgenomen in het bestek. Deze procedure verloopt volgens de geldende wetgeving inzake overheidsopdrachten.
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33651500
Winning prices for comparable contracts
- A quarter below
- €290,000
- Median
- €403,000
- A quarter above
- €1,351,075
Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Immunoglobuline humaine normale pour administration intraveineuse Cliniques universitaires Saint Luc · 22 October 2026 |
CSL BEHRING | €16,277,080 |
| Antimycotica AZ Delta vzw · 21 October 2026 |
Arega Pharma NV Sandoz NV Fresenius Kabi NV Pfizer NV |
€300,945 |
| Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease European Commission, DG SANTE - Health and Food Safety · 1 October 2026 |
Huvepharma EOOD | €2,385,950 |
| Raamovereenkomst voor het leveren van immunoglobulines IV 10% Universitair Ziekenhuis Gent · 24 September 2026 |
CSL BEHRING NV | €27,360,000 |
| Aankoop en levering van plasmaderivaten Algemeen Ziekenhuis Sint-Maria vzw · 15 September 2026 |
CSL BEHRING DEPARTEMENT CENTRAL DE FRACTIONNEMENT Prothya Biosolutions Netherlands B.V. OCTAPHARMA BENELUX |
€18,749,295 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 468342-2026.